Topical Calcineurin Inhibitors (e.g., Tacrolimus Ointment)

Treatment for Eczema

Typical Dosage: Apply thinly 2 times daily

Effectiveness
80%
Safety Score
38%
Clinical Trials
300
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
38
DangerousModerateSafe
Treatment Details
Dosage Range
Apply thinly 2 times daily
Time to Effect
1-2 weeks
Treatment Duration
long-term intermittent use
Evidence Quality
HIGH
Number Needed to Treat (NNT)
4(Treat 4 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$350
Monitoring:$150
Side Effect Mgmt:$50
Total Annual:$550
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$786
Cost per Remission
$1,375
Topical Calcineurin Inhibitors (e.g., Tacrolimus Ointment) Outcomes

for Eczema

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+70%
Remission Rate
+40%
Common Side Effects
Application site burning
+35%
Pruritus
+20%
Erythema
+10%
Skin infection
+7%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov